| Novartis Pharma Schweiz AG - Zykadia, Filmtabletten | | 67233 | | 01 | | Zykadia | | Filmtabletten | | L01ED02 | | Ceritinib | | 16.03.2020 | | |
| | Composition | | ceritinibum 150 mg, cellulosum microcristallinum, hydroxypropylcellulosum, povidonum K 30, carmellosum natricum conexum corresp. natrium 0.05 mg, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, macrogolum 4000, talcum, E 171, E 132, pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Ceritinibum | 150 mg |
| | BAG: Active Agent | Dose |
|---|
| Ceritinibum | 150 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 132 | | color. | | E 171 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Macrogol | 4000 | | | Magnesii Stearas | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 84 | 4003.77 | 4370.75 | A | SL | No |
|
|
